Meril Life Sciences gets 5 years exemption from NPPA for its MeRes100 stent Medical Dialogues Bureau1 March 2020 11:00 AM ISTNew Delhi: The national pharmaceutical regulator NPPA has exempted a new coronary stent developed by Meril Life Sciences from price control for five...
With questions about safety of Meril's Made in India BVS stent, NPPA defers its appeal for price exemption Medical Dialogues Bureau21 Nov 2019 12:09 PM ISTNew Delhi: With an industry association raising health and safety concerns about the flagship Sirolimus-Eluting BioResorbable vascular scaffold system...
Meril Life Sciences gets European Conformity mark for Bioresorbable Scaffold MeRes100 Medical Dialogues Bureau9 Aug 2019 9:45 AM ISTMeril Life Sciences MeRes100 has received both Drug Controller General of India(DCGI) and CE (European Conformity) marketing approval. New Delhi:...
Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent Meghna A Singhania5 March 2019 5:01 PM ISTNew Delhi: In a major setback to Meril Lifesciences, the drug price regulator National Pharmaceutical Pricing Authority(NPPA) has refused to give it...
NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent Meghna A Singhania3 Feb 2019 11:16 AM ISTNew Delhi: A Year after Abbott's launch of biodegradable stents which was later withdrawn globally, Meril Life Sciences has moved the National...
Health Ministry nod to MeRes100- India made bioresorbable cardiac Stent savita thakur thakur24 Feb 2017 11:31 AM ISTNew Delhi: Meril Life Science, a Gujarat based global medical device company has received the green signal from the Health Ministry for the country's...
